Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomis... von Stupp, Roger, Prof, Hegi, Monika E, PhD, Gorlia, Thierry, PhD, Erridge, Sara C, MD, Perry, James, MD, Hong, Yong-Kil, Prof, Aldape, Kenneth D, Prof, Lhermitte, Benoit, MD, Pietsch, Torsten, Prof, Grujicic, Danica, Prof, Steinbach, Joachim Peter, Prof, Wick, Wolfgang, Prof, Tarnawski, Rafał, Prof, Nam, Do-Hyun, Prof, Hau, Peter, Prof, Weyerbrock, Astrid, MD, Taphoorn, Martin J B, Prof, Shen, Chiung-Chyi, MD, Rao, Nalini, MD, Thurzo, László, MD, Herrlinger, Ulrich, MD, Gupta, Tejpal, MD, Kortmann, Rolf-Dieter, Prof, Adamska, Krystyna, MD, McBain, Catherine, MD, Brandes, Alba A, MD, Tonn, Joerg Christian, Prof, Schnell, Oliver, MD, Wiegel, Thomas, Prof, Kim, Chae-Yong, MD, Nabors, Louis Burt, MD, Reardon, David A, MD, van den Bent, Martin J, Prof, Hicking, Christine, MSc, Markivskyy, Andriy, MD, Picard, Martin, PhD, Weller, Michael, Prof

Volltext

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylatedMGMTpromoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised... von Stupp, Roger, Hegi, Monika E, Gorlia, Thierry, Erridge, Sara C, Perry, James, Hong, Yong-Kil, Aldape, Kenneth D, Lhermitte, Benoit, Pietsch, Torsten, Grujicic, Danica, Steinbach, Joachim Peter, Wick, Wolfgang, Tarnawski, Rafal, Nam, Do-Hyun, Hau, Peter, Weyerbrock, Astrid, Taphoorn, Martin J B, Shen, Chiung-Chyi, Rao, Nalini, Thurzo, László, Herrlinger, Ulrich, Gupta, Tejpal, Kortmann, Rolf-Dieter, Adamska, Krystyna, McBain, Catherine, Brandes, Alba A, Tonn, Joerg Christian, Schnell, Oliver, Wiegel, Thomas, Kim, Chae-Yong, Nabors, Louis Burt, Reardon, David A, van den Bent, Martin J, Hicking, Christine, Markivskyy, Andriy, Picard, Martin, Weller, Michael

Volltext